Cardiosense Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 40

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 17

Cardiosense General Information

Description

Developer of a digital biomarker platform designed to leverage multi-sensor devices and proprietary algorithms to detect early signs of disease. The company specializes in building and leveraging non-invasive sensors and artificial intelligence to facilitate cardiac monitoring, enabling healthcare professionals to analyze data and cardiac health signals and track patients' health.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 400 North Aberdeen Street
  • Suite 900
  • Chicago, IL 60642
  • United States
+1 (312)
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Diagnostic Equipment
Corporate Office
  • 400 North Aberdeen Street
  • Suite 900
  • Chicago, IL 60642
  • United States
+1 (312)

Cardiosense Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cardiosense Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 01-Apr-2026 Completed Generating Revenue
7. Accelerator/Incubator 01-Apr-2024 Completed Generating Revenue
6. Early Stage VC (Series A) 08-Dec-2022 Completed Generating Revenue
5. Grant Completed Startup
4. Accelerator/Incubator 20-Jan-2021 Completed Startup
3. Accelerator/Incubator 01-Jun-2020 Completed Startup
2. Angel (individual) Completed Startup
1. University Spin-Out 01-Jan-2020 Completed Startup
To view Cardiosense’s complete valuation and funding history, request access »

Cardiosense Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-4
Series A-3
Series A-2 718,750 $0.000100 8% $0.8 $0.8 1x $0.8 2.36%
Series A-1 15,099,986 $0.000100 8% $1 $1 1x $1 41.28%
To view Cardiosense’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cardiosense Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a digital biomarker platform designed to leverage multi-sensor devices and proprietary algorithms to detect
Monitoring Equipment
Chicago, IL
40 As of 2026

Houston, TX
 

Bend, OR
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cardiosense Competitors (2)

One of Cardiosense’s 2 competitors is Octagos, a Venture Capital-Backed company based in Houston, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Octagos Venture Capital-Backed Houston, TX
Vector (Outcome Management) Venture Capital-Backed Bend, OR
You’re viewing 2 of 2 competitors. Get the full list »

Cardiosense Patents

Cardiosense Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026122728-A1 Sensing systems for measuring and determining physiological parameters of a patient, and devices and methods thereof Pending 03-Dec-2024
WO-2026055256-A1 Systems, devices, and methods for determining physiological information, including handheld and implantable devices Pending 03-Sep-2024
EP-4827580-A1 Systems, devices, and methods for analyzing and presenting physiological information Pending 20-Dec-2023
WO-2025137624-A1 Systems, devices, and methods for analyzing and presenting physiological information Inactive 20-Dec-2023 A61B5/7264

Cardiosense Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cardiosense Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
BayMed Venture Partners Venture Capital Minority
GTF Ventures Venture Capital Minority
Oakwood Circle Ventures Venture Capital Minority
Matter (Consulting Services (B2B)) Accelerator/Incubator Minority
Broadview Ventures Venture Capital Minority
You’re viewing 5 of 17 investors. Get the full list »

Cardiosense FAQs

  • When was Cardiosense founded?

    Cardiosense was founded in 2020.

  • Where is Cardiosense headquartered?

    Cardiosense is headquartered in Chicago, IL.

  • What is the size of Cardiosense?

    Cardiosense has 40 total employees.

  • What industry is Cardiosense in?

    Cardiosense’s primary industry is Monitoring Equipment.

  • Is Cardiosense a private or public company?

    Cardiosense is a Private company.

  • What is Cardiosense’s current revenue?

    The current revenue for Cardiosense is .

  • How much funding has Cardiosense raised over time?

    Cardiosense has raised $15.2M.

  • Who are Cardiosense’s investors?

    BayMed Venture Partners, GTF Ventures, Oakwood Circle Ventures, Matter (Consulting Services (B2B)), and Broadview Ventures are 5 of 17 investors who have invested in Cardiosense.

  • Who are Cardiosense’s competitors?

    Octagos and Vector (Outcome Management) are competitors of Cardiosense.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process